Lumefantrine [clinicaltrials_resource:4cbe3db9e7c9f38f1e48f8e29bda968d]
Lapdap and Coartemether for Uncomplicated Malaria [clinicaltrials:NCT00118794]Longitudinal Antimalarial Combinations in Uganda [clinicaltrials:NCT00123552]Antimalarial Drug Resistance in Mali [clinicaltrials:NCT00127998]Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria [clinicaltrials:NCT00140361]Adherence to Lumefantrine-Artemether [clinicaltrials:NCT00153491]Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi [clinicaltrials:NCT00164710]Combination Antimalarials in Uncomplicated Malaria [clinicaltrials:NCT00203801]Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines [clinicaltrials:NCT00229775]Drug Interaction Study Between Antimalarial and Anti-HIV Medications [clinicaltrials:NCT00266058]Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon [clinicaltrials:NCT00297882]Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status [clinicaltrials:NCT00304980]Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotyping [clinicaltrials:NCT00336375]Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria [clinicaltrials:NCT00344006]Randomized Trial on Effectiveness of ACTs in Ghana [clinicaltrials:NCT00374205]Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function [clinicaltrials:NCT00386750]Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria. [clinicaltrials:NCT00386763]clinicaltrials:NCT00393679Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children [clinicaltrials:NCT00406146]clinicaltrials:NCT00422084Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau [clinicaltrials:NCT00426439]The Impact of Artemether-Lumefantrine on Genes Associated With Antimalarial Resistance [clinicaltrials:NCT00440752]clinicaltrials:NCT00444106Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials [clinicaltrials:NCT00451139]ACT MALI: Treatment of Malaria Based on Combination Therapies [clinicaltrials:NCT00452907]Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania [clinicaltrials:NCT00454961]Treatment of Uncomplicated Malaria in Benin [clinicaltrials:NCT00460369]Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy [clinicaltrials:NCT00495508]clinicaltrials:NCT00527800Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria [clinicaltrials:NCT00529867]clinicaltrials:NCT00540202Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks [clinicaltrials:NCT00540410]Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients [clinicaltrials:NCT00541385]Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir [clinicaltrials:NCT00619944]Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients [clinicaltrials:NCT00620438]clinicaltrials:NCT00677833clinicaltrials:NCT00694694Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations [clinicaltrials:NCT00697892]Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria [clinicaltrials:NCT00709969]Treatment of Non-falciparum Malaria [clinicaltrials:NCT00725777]Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults [clinicaltrials:NCT00790881]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Lumefantrine [clinicaltrials_resource:4cbe3db9e7c9f38f1e48f8e29bda968d]
Bio2RDF identifier
4cbe3db9e7c9f38f1e48f8e29bda968d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4cbe3db9e7c9f38f1e48f8e29bda968d
identifier
clinicaltrials_resource:4cbe3db9e7c9f38f1e48f8e29bda968d
title
Lumefantrine
@en
type
label
Lumefantrine [clinicaltrials_resource:4cbe3db9e7c9f38f1e48f8e29bda968d]
@en